drugset / Trial / NCT00943098

Evaluation of the Efficacy and Safety of Diclofenac HPBCD 75mg/ml in Treatment of Pain Following Dental Surgery

NCT00943098

Phase 3 Completed 142 enrolled IBSA Institut Biochimique SA
RandomizedParallel-groupDouble-blindTreatment

Summary

The present study is aimed at demonstrating the therapeutic equivalence of diclofenac HPBCD 75mg/1ml s.c. with the marketed reference product, Voltarol® 75mg/3ml i.m. in the treatment of acute moderate-to-severe pain after dental impaction surgery.

Timeline

Start
2009-09
Primary completion
2010-03
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 75 mg Subcutaneous

Indications

No indication recorded.